The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis
Open accessAbstract
In breast cancer, inactivating point mutations in the E-cadherin gene are frequently found in invasive lobular carcinoma (ILC) but never in invasive ductal carcinoma (IDC). Lobular carcinoma in situ (LCIS) adjacent to ILC has previously been shown to lack E-cadherin expression, but whether LCIS without adjacent invasive carcinoma also lacks E-cadherin expression and whether the gene mutations present in ILC are already present in LCIS is not known. We report here that E-cadherin expression is absent in six cases of LCIS and present in 150 cases of ductal carcinoma in situ (DCIS), both without an adjacent invasive component. Furthermore, using mutation analysis, we could demonstrate the presence of the same truncating mutations and loss of heterozygosity (LOH) of the wild-type E-cadherin in the LCIS component and in the adjacent ILC. Our results indicate that E-cadherin is a very early target gene in lobular breast carcinogenesis and plays a tumour-suppressive role, additional to the previously suggested invasion-suppressive role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator
Takeichi, M. (1991) · Science · doi:10.1126/science.2006419 · Cited by 3,284
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656 · cited 1×
“Down-regulation of E-cadherin can also occur by hypermethylation of the promoter region of E-cadherin and may lead to altered tumour cell behaviour, although this is not restricted to a distinct tumour type (Graff etal, 1995; Yoshiura et al, 1995).”
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., & Baylin, S. B. (1995) · PubMed · Cited by 796
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., & van Roy, F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00301.x · Cited by 775
Self-citationSilencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.
Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T., & Hirohashi, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7416 · Cited by 645
Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll, R., Mitze, M., Frixen, U. H., & Birchmeier, W. (1993) · PubMed · Cited by 520
Berx, G., Cleton-Jansen, A., Strumane, K., de Leeuw, W. J., Nollet, F., Roy, F. M. V., & Cornelisse, C. J. (1996) · PubMed · Cited by 461
Self-citationGamallo, C., Palacios, J., Suarez, A., Pizarro, Á., Navarro, P., Quintanilla, M., & Cano, A. (1993) · PubMed · Cited by 410
Isola, J. J., DeVries, S., Chu, L. W., Ghazvini, S., & Waldman, F. (1994) · PubMed Central · Cited by 398
Cited by
N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression
Nieman, M. T., Prudoff, R. S., Johnson, K. R., & Wheelock, M. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.3.631 · Cited by 789
Nollet, F., Kools, P., & van Roy, F. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3777 · Cited by 698
Self-citationMutations of the human E-cadherin (CDH1) gene
Berx, G., Becker, K.-F., Höfler, H., & van Roy, F. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:4<226::aid-humu2>3.0.co;2-d · Cited by 607
Self-citationDerksen, P. W. B., Liu, X., Saridin, F., van der Gulden, H., Zevenhoven, J., Evers, B., van Beijnum, J. R., Griffioen, A. W., Vink, J., Krimpenfort, P., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.013 · Cited by 591
Self-citationCorrelation of Snail expression with histological grade and lymph node status in breast carcinomas
Blanco, M. J., Moreno-Bueno, G., Sarrio, D., Locascio, A., Cano, A., Palacios, J., & Nieto, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205416 · Cited by 576
Histological types of breast cancer: How special are they?
Weigelt, B., Geyer, F. C., & Reis-Filho, J. S. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.004 · Cited by 572
Gottardi, C. J., Wong, E., & Gumbiner, B. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1049 · Cited by 544
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
Berx, G., & Roy, F. V. (2001) · Breast Cancer Research · doi:10.1186/bcr309 · Cited by 463
Self-citationHistological and molecular types of breast cancer: is there a unifying taxonomy?
Weigelt, B., & Reis-Filho, J. S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.166 · Cited by 457
E-cadherin—catenin cell—cell adhesion complex and human cancer
Wijnhoven, B. P. L., Dinjens, W. N. M., & Pignatelli, M. (2000) · Journal of British Surgery · doi:10.1046/j.1365-2168.2000.01513.x · Cited by 451
Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B., & Herman, J. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2727 · Cited by 393
Cell–cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion
Ilina, O., Gritsenko, P. G., Syga, S., Lippoldt, J., La Porta, C. A. M., Chepizhko, O., Grosser, S., Vullings, M., Bakker, G.-J., Starruß, J., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0552-6 · Cited by 375
Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics
Reed, A. E. M., Kutasovic, J. R., Lakhani, S. R., & Simpson, P. T. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0519-x · Cited by 373
Breast cancer precursors revisited: molecular features and progression pathways
Lopez‐Garcia, M. A., Geyer, F. C., Lacroix‐Triki, M., Marchió, C., & Reis‐Filho, J. S. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03568.x · Cited by 347
Lombaerts, M., van Wezel, T., Philippo, K., Dierssen, J. W. F., Zimmerman, R. M. E., Oosting, J., van Eijk, R., Eilers, P. H., van de Water, B., Cornelisse, C. J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602996 · Cited by 346
Self-citationKeller, G., Vogelsang, H., Becker, I., Hutter, J., Ott, K., Candidus, S., Grundei, T., Becker, K.-F., Mueller, J., Siewert, J. R., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65129-2 · Cited by 287
Acs, G., Lawton, T. J., Rebbeck, T. R., LiVolsi, V. A., & Zhang, P. J. (2001) · American Journal of Clinical Pathology · doi:10.1309/fdhx-l92r-batq-2ge0 · Cited by 280
Abdel-Fatah, T. M. A., Powe, D. G., Hodi, Z., Lee, A. H. S., Reis-Filho, J. S., & Ellis, I. O. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213368.41251.b9 · Cited by 271
Metadata
- Authors
- Vos, C., Cleton-Jansen, A., Berx, G., de Leeuw, W., ter Haar, N., van Roy, F., Cornelisse, C., Peterse, J., & van de Vijver, M.
- Venue
- British Journal of Cancer
- Published
- 1997-11
- Volume
- 76
- Issue
- 9
- Pages
- 1131-1133
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2067365317
- Cited by
- 347
- References
- 12
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.